Company: VMCWF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001827
Chunk: 82

Company: Valuence Merger Corp. I
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 82
---
 of reducing the likelihood of derivative litigation against our officers and
directors, even though such an action, if successful, might otherwise benefit us and our shareholders. Furthermore, a shareholder’s
investment may be adversely affected to the extent we pay the costs of settlement and damage awards against our officers and directors
pursuant to these indemnification provisions.

Any
negative developments involving our management, directors and persons or companies with which they are currently or have been affiliated,
including civil disputes, litigation, government or other investigations or other actual or alleged misconduct, unrelated to our business
affairs could materially impact our ability to consummate an initial Business Combination.

Our
members of our management team, our directors, and persons or companies with which they are affiliated have been, and in the future will
continue to be, involved in a wide variety of business and other activities. As a result of such involvement, we may be exposed to the
risk of negative developments relating to members of our management, directors and persons or companies with which they are affiliated,
including civil disputes, litigation, governmental or other investigations or other actual or alleged misconduct relating to their affairs
unrelated to our Company. Any such development, including any negative publicity related thereto, may be detrimental to our reputation,
negatively affect our ability to identify and complete an initial Business Combination in a material manner and may have an adverse effect
on the price of our securities.

43

RISKS
RELATING TO OUR SECURITIES

Nasdaq has delisted our securities from trading on its exchange, which
could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions.

Nasdaq
rule IM-5101-2 requires that a SPAC complete one or more business combinations within 36 months of the effectiveness of its initial
public offering registration statement, which, in our case, was February 28, 2025. We did not complete an initial Business
Combination by that date and so Nasdaq determined to delist our Units, Class A ordinary shares and Public Warrants from trading on
March 11, 2025. Our securities are quoted on an over-the-counter market. As a result, we could face significant material adverse
consequences, including:

    ●
    a
    limited availability of market quotations for our securities;

    ●
    reduced
    liquidity for our securities;

    ●
    a
    determination that our Class A ordinary shares are a “penny stock” which will require